
WA-based cancer pharmaceutical start-up secures CUREator funding
9 May 2024
WA’s nation-leading immunisation program for babies slashes RSV hospital admissions
An Australian-first study demonstrating the effectiveness of a new immunisation against respiratory syncytial virus (RSV) for babies found it to be almost 90 per cent effective in reducing hospitalisation rates and helped more than 500 WA families avoid a hospital stay.
Read more about WA’s nation-leading immunisation program for babies slashes RSV hospital admissionsWA-based cancer pharmaceutical start-up secures CUREator funding
9 May 2024
Early Years Partnership budget boost welcomed
3 May 2024
The Kids researchers help quantify global impact of life-saving vaccines
2 May 2024
Prestigious funding secures critical child health research programs
2 May 2024
Clinical trial recruiting babies for RSV and hMPV vaccine study
1 May 2024
Birth trauma investigation to end Embracing the Mind S2
30 April 2024
News you can use: how to cope with burnout
30 April 2024
Trial tests which COVID-19 booster combos ‘boost’ immunity
26 April 2024
New national trial leverages childcare to boost physical activity in young Aussie kids
23 April 2024
Global study finds human air travel culprit for RSV variant spread
22 April 2024
2024 Run for a Reason – Team The Kids
19 April 2024
The Kids welcomes support for autistic students
25 March 2024